Filing Details

Accession Number:
0000899243-20-004277
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-12 16:56:43
Reporting Period:
2019-08-23
Accepted Time:
2020-02-12 16:56:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1793294 Ppd Inc. PPD Services-Commercial Physical & Biological Research (8731) 453806427
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1801744 Glen Donovan C/O Ppd, Inc.
929 North Front Street
Wilmington NC 28401
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Non-Voting Common Stock Disposition 2020-02-10 5,333 $0.00 0 No 4 D Direct
Common Stock Acquisiton 2020-02-10 5,333 $0.00 5,333 No 4 A Direct
Common Stock Acquisiton 2020-02-10 500 $27.00 5,833 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 D Direct
No 4 A Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Non-Voting Common Stock Stock Options (Right to Buy) Acquisiton 2019-08-23 3,785 $0.00 3,785 $19.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,785 2029-08-23 No 4 A Direct
Footnotes
  1. Upon the completion of the initial public offering of PPD, Inc. (the "Issuer"), all shares of the Issuer's non-voting common stock automatically converted into shares of the Issuer's voting common stock on a one-for-one basis.
  2. Shares were acquired in a directed share program in connection with the Issuer's initial public offering.
  3. Represents stock options previously granted to the reporting person on August 23, 2019. These stock options were already reflected on the reporting person's previously filed Form 3.
  4. Represents 3,785 stock options which are unvested and will vest in equal annual installments on August 23, 2020, August 23, 2021, August 23, 2022, August 23, 2023 and August 23, 2024. Does not include an additional 3,785 stock options with an exercise price of $19.24 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2019-2023.